S&P/ASX 200 Index (ASX: XJO) shares are barely in the green on Tuesday as investors wait for more news about US-Iran negotiations.

Trading Economics analysts say there are signs of progress from talks between American and Iranian officials in Switzerland.

The analysts said:

In a key development, Washington granted Iran a 60-day license to sell oil on international markets, raising expectations of a quicker recovery in global supply.

Traffic through the Strait of Hormuz has also picked up, with producers including Kuwait and the United Arab Emirates finding alternative routes to export energy, while Iran shipped more than 30 million barrels over the past week. 

Meanwhile, two experts give us their views on three ASX shares.

Let's check them out. 

Flight Centre Travel Group Ltd (ASX: FLT)

The Flight Centre share price is $11.85, down 0.75% today and down 21% in the calendar year to date (YTD). 

Belinda Moore from Morgans has a buy rating on this ASX 200 consumer discretionary share. 

Moore was not surprised after the company downgraded its guidance because of the Iran war.

Due to strong cash reserves and a depressed share price, Flight Centre also announced a new buyback of up to $200 million.

Moore said: 

Given recent downgrades from other travel industry peers due to the conflict in the Middle East, FLT's downgrade wasn't a surprise.

While a peace agreement and eased travel restrictions are positive, we think 1H27 will still be challenging.

We forecast a strong recovery in 2H27. If it wasn't for this conflict, FLT would have had a great year given its results for the first nine months were strong.

We are buyers of FLT because when operating conditions ultimately improve, both its earnings and share price will be materially higher.

Lottery Corporation Ltd (ASX: TLC)

The Lottery Corporation share price is $5.55, down 0.2% today and up 7% YTD. 

Toby Grimm from Baker Young has a hold rating on Lottery Corporation shares.

On The Bull this week, Grimm explained:

Securing a 40-year extension as Victoria's exclusive lottery operator adds certainty given the importance of the contract and its longer than expected duration.

However, operating performance has been subdued amid challenging consumer conditions and unfavourable jackpot outcomes.

The company continues to identify cost savings, which will help fund digital investment.

The stock is trading at fair value, but we believe the stock appeals in the longer term, supported by a fully franked dividend yield.

Supply Network Ltd (ASX: SNL)

The Supply Network share price is $32.74, down 0.6% today and up 2% YTD. 

Grimm has a sell rating on this ASX 300 consumer discretionary share. 

He said: 

The truck and bus parts supplier has built a leading position in an industry benefiting from an ageing fleet on our roads. Group sales revenue of $200.1 million in the first half of 2026 was up 16.9 per cent on the prior corresponding period.

However, in our view, the stock screens as expensive given it was recently trading on about 33 times estimated earnings in 2026.

Current fuel price uncertainties present another challenge and may impact freight demand in the near term.

The post Buy, hold, sell: Flight Centre, Supply Network, Lottery Corporation shares appeared first on The Motley Fool Australia.

More reading

• 2 ASX shares highly recommended to buy: Experts
• Here are the 10 most shorted ASX shares
• 8 ASX shares with 30% to 220% upside ahead: Experts
• Top brokers name 3 ASX shares to buy next week
• Brokers name 3 ASX shares to buy right now

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Supply Network Ltd and The Lottery Corporation. The Motley Fool Australia has recommended Flight Centre Travel Group, Supply Network Ltd, and The Lottery Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are 0.14% higher at 8,828.7 points on Tuesday. 

The fastest rising ASX 200 share today is WiseTech Global Ltd (ASX: WTC), which has recovered 4% after yesterday's smashing.

ASX 200 healthcare shares Telix Pharmaceuticals Ltd (ASX: TLX) and Mesoblast Ltd (ASX: MSB) are also among the top risers today.

Both stocks are up by more than 3.5%.

Meanwhile, let's check out 3 ASX 200 shares with new ratings from the experts (courtesy The Bull).

Charter Hall Group (ASX: CHC)

The Charter Hall share price is $22.73, down 0.5% today and down 7% in the calendar year to date (YTD). 

Toby Grimm from Baker Young has a buy rating on this real estate investment trust (REIT).

The analyst said: 

Australia's leading diversified property group has benefited from a strong funds management performance driving multiple earnings upgrades in the past financial year.

With the strong operational trend continuing amid a potential respite in interest rates, the stock offers compelling exposure in a lagging sector that may be a beneficiary of a swing against banks.

The shares have been enjoying favourable momentum since May 20, increasing from $18.80 to trade at $23.15 on June 18.

Cochlear Ltd (ASX: COH)

The Cochlear share price is $112.38, down 0.5% today and down 57% YTD.

Christopher Watt from Bell Potter has a hold rating on this ASX 200 healthcare share. 

Watt explained: 

The long term opportunity for this hearing implants maker remains compelling, supported by a large addressable market, strong brand position and an attractive product pipeline.

However, near term trading conditions have softened in response to weaker referral activity in the US, hospital capacity constraints in Europe and reimbursement changes in China.

Until there's clearer evidence that volumes are stabilising, a more balanced stance is appropriate.

The long term growth story and product pipeline remain intact.

The S&P/ASX 200 Health Care Index (ASX: XHJ) fell to a 9-year low on 3 June due to many industry headwinds over the past year.

Since then, ASX 200 healthcare shares have been on a comeback, rising 11.5% compared to a 0.4% bump for the broader ASX 200.

Northern Star Resources Ltd (ASX: NST)

The Northern Resources share price is $20.93, down 1.3% on Tuesday and down 14% YTD. 

Grimm has a sell rating on this ASX 200 gold mining share.

He explained:

The emergence of prominent US based activist investor Elliott Investment Management has prompted optimism surrounding the gold miner.

However, in our view, it doesn't alter the underperformance of NST's asset base involving production volumes, costs and capital expenditure requirements.

A new management team will likely rebase expectations. But we would seek alternative gold exposure for those still playing the theme.

The shares have fallen from $31.73 on March 2 to trade at $21.44 on June 18.

Elliot Investment recently disclosed it has a 3% to 4% stake in Northern Star shares.

It also suggested ways that Northern Star management could improve returns for shareholders.

You can read Northern Star's response here.

The post Buy, hold, sell: Charter Hall, Northern Star, Cochlear shares appeared first on The Motley Fool Australia.

More reading

• What on earth's going on with Cochlear shares?
• 5 things to watch on the ASX 200 on Tuesday
• With the gold price up on Monday, are Northern Star shares a good buy now?
• 3 ASX healthcare shares to sell despite signs of sector rebound
• Why CSL, Westpac, and this big-name ASX 200 share could be sells

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and Telix Pharmaceuticals. The Motley Fool Australia has recommended Cochlear and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares started the day in the red on Monday but are rising in mid-morning trading.

ASX 200 shares are currently up 0.1% to 8,840.3 points.

Among the 11 market sectors, the consumer discretionary sector is in the lead today, up 0.6%.

The tech sector is the laggard, down 0.7%.

Meanwhile, on The Bull this week, three experts give us their opinions and recommendations on three ASX 200 shares.

Let's take a look.

JB Hi-Fi Ltd (ASX: JBH)

The JB Hi-Fi share price is $78.94, up 1.3% today and down 18% in the calendar year to date (YTD). 

Toby Grimm from Baker Young has a buy rating on this ASX 200 consumer discretionary share.

Grimm said: 

The share price of this consumer electronics giant has significantly fallen since August 2025 in response to cost of living and supply chain cost pressures and increasing interest rates.

Despite these issues, JBH is expected to deliver positive sales and underlying earnings growth during the next two years.

The outlook for consumer electronics remains structurally sound. Diminishing rate hike expectations is another positive.

The stock is trading on more appealing multiples compared to 2025 and was recently offering an attractive dividend yield above 5 per cent.

Following three interest rate rises already this year, some experts expect the Reserve Bank's next move will be a cut due to low GDP growth, recent softer inflation data, and consumer sentiment falling to one of its weakest levels in 50 years.

Given the market looks 6 to 12 months ahead, it seems that value investors may be looking for opportunities in ASX 200 retail shares today.

Santos Ltd (ASX: STO)

Santos shares are $7.31 apiece, up 0.1% today and up 19% YTD. 

Niv Dagan from Peak Asset Management has a hold rating on this ASX 200 energy share. 

Dagan said much of the near-term upside for Santos shares depends on successful execution of major projects.

Barossa is online and ramping up, while the Pikka phase 1 in Alaska has started production, with both expected to materially increase free cash flow at plateau rates.

Management is also targeting at least 60 per cent of free cash flow for shareholder returns and a $2.5 billion reduction in net debt by 2030.

However, the investment case still relies on commodity prices, capital discipline and the delivery of a large multi-year development pipeline across Australia, Papua New Guinea and Alaska.

Westpac Banking Corp (ASX: WBC)

The Westpac share price is $35.03, up 0.1% today and down 10% YTD.

Christopher Watt from Bell Potter Securities has a sell rating on this ASX 200 bank share.

Watt explained: 

The business is improving on the metrics that matter, but the operating backdrop is weakening.

Mortgage applications since the Federal Budget in May are below the prior two quarters, pointing to a slowdown in housing credit growth into next year.

Proposed tax changes to capital gains tax and negative gearing have soured sentiment, and there's no fresh financial guidance to lean on.

With Westpac's stock trading near the top of its range amid a possible earnings downgrade, I see more downside than upside from here.

The Federal Government has proposed that the 50% capital gains tax (CGT) discount for assets held longer than 12 months be replaced by a cost base inflation indexation method from 1 July 2027. Additionally, a minimum 30% CGT rate will apply.

To incentivise new housing, investors in new residential properties will be able to choose between the two CGT methods when they sell.

Also, from 1 July 2027, investors will not be able to negatively gear established properties purchased for investment, but will be able to do so with new homes.

The post Buy, hold, sell: JB Hi-Fi, Westpac, Santos shares appeared first on The Motley Fool Australia.

More reading

• Down 17%: What should I do with my Westpac shares now?
• With oil prices falling, should I still buy Santos shares now?
• The US-Iran peace deal just wavered. Here is what this means for these ASX shares
• 5 things to watch on the ASX 200 on Tuesday
• Why CSL, Westpac, and this big-name ASX 200 share could be sells

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Healthcare shares are underperforming today, down 0.33%, while the benchmark S&P/ASX 200 Index (ASX: XJO) is 0.15% lower.

Healthcare led the 11 market sectors last week with a 4.84% rise compared to a 0.28% lift for the ASX 200.

The sector has been a poor performer over the past 12 months, down 39% overall amid many industry challenges.

These include US currency headwinds; three interest rate rises in Australia; cost of living pressures leading people to delay procedures; higher shipping costs; new limits on insurance payouts in some nations; higher wage costs; and regulatory uncertainty in the US.

However, things may be changing.

On 3 June, the S&P/ASX 200 Health Care Index (ASX: XHJ) touched a 9-year low of 21,947.2 points.

Since then, ASX 200 healthcare shares have lifted 12.8% while the broader ASX 200 has managed only a 0.37% gain.

This may signal that a sector rebound has begun.

Despite these green shoots, experts maintain sell ratings on several ASX 200 healthcare shares, as showcased on The Bull this week.

Let's hear them out.

CSL Ltd (ASX: CSL)

The CSL share price is $114.30, down 1.6% today and down 52% over 12 months.

Niv Dagan from Peak Asset Management has a sell rating on the market's largest ASX 200 healthcare share.

The expert commented: 

A sell rating is justified as this biotechnology giant has materially downgraded its fiscal year 2026 outlook while announcing about $5 billion of additional non-cash pre-tax impairments across fiscal years 2026 and 2027.

Revenue expectations have been reduced due to US immunoglobulin channel normalisation and weaker albumin prices in China.

The CSL Vifor acquisition has under-performed. Also, government healthcare cost pressures and a higher interest rate environment present ongoing challenges for the biotechnology sector, further weighing on sentiment.

Cochlear Ltd (ASX: COH)

The Cochlear share price is $117.55, down 0.5% today and down 60% over 12 months.

Dagan also has a sell rating on this ASX 200 healthcare share. 

He explained: 

In April, the hearing implants maker materially reduced its fiscal year 2026 underlying net profit guidance to between $290 million and $330 million from between $435 million from $460 million in February.

The downgrade was a response to weaker than expected demand in developed markets amid Middle East uncertainty, lower margins and foreign exchange headwinds.

Hospital capacity constraints amid softer consumer sentiment and reduced referral activity are weighing on implant volumes, while cost base restructuring is likely to impact earnings in the near term.

Monash IVF Group Ltd (ASX: MVF)

The Monash IVF share price is steady on Monday at 71 cents.

This ASX 200 healthcare share has defied sector trends to rise 12.7% over 12 months.

But it's been a bumpy road, as the chart below shows, and Christopher Watt from Bell Potter gives the stock a sell rating.

Watt said: 

The fertility services company recently downgraded fiscal year 2026 guidance. It now expects underlying net profit after tax to range between $17 million and $18 million.

Across the Australian market, stimulated cycle volumes were down 4.7 per cent on a rolling three month basis to the end of April when compared to the prior corresponding period.

Cost-of-living pressures and declining birth rates are structural headwinds for the whole industry.

New leadership has a genuine reset opportunity, but until there's evidence of an industry-wide recovery, I remain cautious.

The post 3 ASX healthcare shares to sell despite signs of sector rebound appeared first on The Motley Fool Australia.

More reading

• What on earth's going on with Cochlear shares?
• 3 cheap ASX shares that could be hiding in plain sight
• Why A2 Milk, Calix, CSL, and Ioneer shares are charging higher today
• Buy, hold, sell: Charter Hall, Northern Star, Cochlear shares
• Down 53%, is it time to throw in the towel on CSL shares?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Cochlear. The Motley Fool Australia has recommended CSL and Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.2% to 8,815.3 points on Monday.

The market is jittery after Iran said it had re-closed the Strait of Hormuz over the weekend after Israel bombed Lebanon.

US and Iran officials are in Switzerland for further discussions after both parties signed an interim peace deal last week.

Meanwhile on The Bull this week, two experts give us their views and ratings on three ASX 200 shares.

Let's check them out. 

Life360 Inc (ASX: 360)

The Life360 share price is $23.88, up 0.2% today and down 26% in the calendar year to date (YTD). 

Christopher Watt from Bell Potter Securities has a buy rating on this ASX 200 tech share. 

Watt explains: 

This information technology company provides a mobile networking safety app for families.

Active user growth is rebounding following a technical issue, while paying circle growth, which drives revenue, recently exceeded expectations.

Guidance was upgraded. Once focus returns to paying circles, I expect a re-rating to follow.

The upcoming August result is a catalyst.

The company has been enjoying strong price momentum, with the shares rising from $17.91 on May 20 to trade at $22.54 on June 18.

Woodside Energy Group Ltd (ASX: WDS)

The Woodside share price is $29.18, up 0.5% today and up 23% YTD. 

Niv Dagan from Peak Asset Management has a hold rating on this ASX 200 energy share. 

Dagan said: 

Operationally, the energy giant continues to execute strongly. It achieved an 11 per cent increase in the average realised price of a barrel of oil equivalent in the first quarter of 2026 when compared to the fourth quarter of financial year 2025.

However, quarterly production fell by 8 per cent due to seasonal weather events. The Scarborough energy project was 96 per cent complete and remains on track for first LNG cargo in the fourth quarter of 2026.

Other major projects remain on budget and on schedule.

CSL Ltd (ASX: CSL)

CSL shares are $113.09, down 2.8% today and down 34% YTD. 

Dagan has a sell rating on this ASX 200 healthcare share.

The analyst said CSL shares deserve a sell rating after the company downgraded its outlook for FY26.

He commented: 

A sell rating is justified as this biotechnology giant has materially downgraded its fiscal year 2026 outlook while announcing about $5 billion of additional non-cash pre-tax impairments across fiscal years 2026 and 2027.

Revenue expectations have been reduced due to US immunoglobulin channel normalisation and weaker albumin prices in China.

The CSL Vifor acquisition has under-performed. Also, government healthcare cost pressures and a higher interest rate environment present ongoing challenges for the biotechnology sector, further weighing on sentiment.

The post Buy, hold, sell: Life360, Woodside, CSL shares appeared first on The Motley Fool Australia.

More reading

• Woodside shares sink again as oil price pressure outweighs new gas deal
• 3 cheap ASX shares that could be hiding in plain sight
• 3 reasons to buy the dip on Life360 shares today
• Why A2 Milk, Calix, CSL, and Ioneer shares are charging higher today
• Down 53%, is it time to throw in the towel on CSL shares?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

iShares Core S&P/ASX 200 ETF (ASX: IOZ) offers a simple way to invest in the Australian share market.

This indices-tracking ASX exchange-traded fund (ETF) seeks to mirror the total returns of the S&P/ASX 200 Index (ASX: XJO).

This means IOZ ETF investors own a piece of each of Australia's top 200 listed companies by market capitalisation.

According to the latest ASX data, Australians have almost $8.69 billion invested in the IOZ ETF.

Today, the IOZ ETF's portfolio has changed because the ASX 200 Index has been updated.

Every quarter, S&P Dow Jones Indices rebalances Australia's leading indexes, including the ASX 200.

Some companies are added, and some are taken out, depending on how their valuation has changed and other criteria.

The June quarter rebalance takes effect today.

When the index changes, BlackRock is compelled to update the IOZ ETF holdings to match the index.

This ensures investors will receive returns that mirror the performance of the index, minus management fees.

Own IOZ ETF? Here are the new shares you own

As of today, investors now own the following newly appointed ASX 200 shares.

You no longer own these ASX shares

These companies were dumped from the ASX 200 in the June rebalance. As a result, they are out of the IOZ ETF portfolio.

Aussie investors love their ASX ETFs

ASX ETFs like IOZ allow investors to buy a basket of local or international shares in one trade for a single brokerage fee.

ETFs also have low ongoing management fees. BlackRock charges IOZ ETF investors 0.05% per year.

IOZ ETF has delivered an average annual return, comprising capital growth and dividends, of 8.26% since inception.

The post Invested in IOZ ETF? Your portfolio has changed today appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• What on earth's going on with Cochlear shares?
• Liontown shares crash 18% in a month: What happened?
• Why is the ASX 200 stuck in the red today?
• 3 ASX shares with 39% to 141% growth ahead of them: Experts

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BlackRock, Electro Optic Systems, SiteMinder, and Temple & Webster Group. The Motley Fool Australia has positions in and has recommended SiteMinder. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares rose 0.3% last week after the US and Iran agreed to an interim peace deal.

In 2026, ASX 200 shares have managed just a 1.1% rise after the unexpected global oil shock made investors very nervous.

However, experts are confident of strong growth ahead for a few select ASX stocks.

Let's take a look at some examples.

Droneshield Ltd (ASX: DRO)

The Droneshield share price closed steady at $2.74 on Friday.

Over the past month, this ASX 200 industrials share has fallen 7%.

Canaccord Genuity renewed its buy rating on Droneshield shares last week.

The broker has a 12-month price target of $3.75.

This suggests a potential 40% upside ahead.

Flight Centre Travel Group Ltd (ASX: FLT)

The Flight Centre share price finished at $11.92, down 1.6%, on Friday.

This ASX 200 travel share has ripped 19% over the past month.

Morgan Stanley reiterated its buy rating on Flight Centre shares with a price target of $16.

This implies potential capital gains of 34% ahead.

Seek Ltd (ASX: SEK)

The Seek share price closed 2.2% higher at $13.63 on Friday.

Over the past six months, this ASX 200 communications share has fallen 41%.

Citi reaffirmed its buy rating on Seek shares with a 12-month target of $24.15.

This suggests a potential near-80% upside ahead.

Turalco Gold Ltd (ASX: TCG)

Turalco Gold shares closed out the week at 55 cents apiece.

This ASX gold share has fallen 33% over six months.

Canaccord Genuity renewed its buy rating on Turalco Gold shares with a $1.75 target.

This implies potential capital growth of 220% over the next year.

IDP Education Ltd (ASX: IEL)

The IDP Education share price closed 6.7% higher at $2.56 on Friday.

Over the past six months, this ASX consumer discretionary share has tumbled 56%.

The language testing and international student placement provider was officially kicked out of the ASX 200 today.

UBS renewed its buy rating on IDP Education shares with a $5.15 target.

This suggests a potential 103% upside ahead.

Credit Corp Group Ltd (ASX: CCP)

The Credit Corp share price closed 0.9% higher at $13.07 on Friday.

This ASX financial share share has lifted 13% over the past four weeks.

Canaccord Genuity reiterated its buy rating on Credit Corp shares with a price target of $19.70.

This implies a potential 51% upside ahead.

Brazilian Rare Earths Ltd (ASX: BRE)

The Brazilian Rare Earths share price finished at $4.91, down 5%, on Friday.

Over the past month, this ASX rare earths share has fallen 16%.

Ord Minnett renewed its buy rating on Brazilian Rare Earths shares last week.

The broker has a 12-month price target of $6.95.

This suggests a potential 45% upside ahead.

Resmed CDI (ASX: RMD)

The Resmed share price closed 0.7% higher at $26.68 on Friday.

Over the past six months, this ASX 200 healthcare share has lost 27% of its valuation.

Citi renewed its buy rating on Resmed shares with a $38 target.

This suggests a potential 42% upside ahead.

The post 8 ASX shares with 30% to 220% upside ahead: Experts appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: How does Morgans rate these ASX shares?
• Buy, hold, sell: Flight Centre, Supply Network, Lottery Corporation shares
• Should I buy CSL and ResMed shares right now?
• 2 ASX shares tipped to grow 50% or more in the next 12 months
• 2 ASX shares highly recommended to buy: Experts

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX 200 healthcare shares led the 11 market sectors last week with a 4.84% increase over the five trading days.

The S&P/ASX 200 Index (ASX: XJO) lifted 0.28% amid a US-Iran interim peace deal and oil prices dropping to pre-war levels.

The ASX 200 finished the week at 8,828.7 points.

It's potentially significant that healthcare was out in front last week given the sector's poor performance over the past 12 months.

The S&P/ASX 200 Health Care Index (ASX: XHJ) is down 39% over 12 months and down 25% in the calendar year to date.

The healthcare index hit a 9-year low of 21,947.2 points on 3 June.

Samy Sriram, a market analyst at online investment platform, Stake, says healthcare companies have had many headwinds.

They include currency challenges for those reporting in US dollars; three interest rate rises in Australia; cost of living pressures; higher shipping costs; new caps on insurance payouts in some nations; higher labour costs; and regulatory uncertainty in the US.

However, markets are cyclical. At some point in a downturn, share prices fall to levels that offer too much value to ignore, and investors dive back in.

Does 3 June represent that pivot point?

ASX 200 healthcare shares have increased 13% since 3 June compared to just a 0.49% bump for the broader benchmark index.

Let's review some individual company performances last week.

Healthcare shares led the ASX sectors last week

The CSL Ltd (ASX: CSL) share price ascended 8.19% to close at $116.32 on Friday.

Sigma Healthcare Ltd (ASX: SIG) shares rose 4.55% to $2.76 apiece.

Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) shares dropped 2.17% to $31.53.

Pro Medicus Ltd (ASX: PME) shares lifted 5.37% to $172.80.

Resmed CDI (ASX: RMD) shares fell 3.75% to $26.68.

Sonic Healthcare Ltd (ASX: SHL) shares eased 0.74% to $20.05.

The Ramsay Health Care Ltd (ASX: RHC) share price lifted 1.73% to $39.49.

The Cochlear Ltd (ASX: COH) share price shot 13.87% higher to $118.14.

Telix Pharmaceuticals Ltd (ASX: TLX) shares increased 6.62% to $14.50.

The Ansell Ltd (ASX: ANN) share price rose 2.46% to $29.99.

The EBOS Group Ltd ASX: EBO) share price fell 3.87% to $16.91.

Mesoblast Ltd (ASX: MSB) shares ripped 9.23% to $2.13 apiece.

Megastar ASX 200 healthcare share, 4DMedical Ltd (ASX: 4DX), rocketed 23.37% to $4.54.

4DMedical shares are up 1,716% over 12 months.

ASX 200 market sector snapshot

Here's how the 11 market sectors stacked up last week, according to CommSec data.

Over the five trading days:

The post Healthcare shares led the ASX 200 last week. Is a sector comeback underway? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• What on earth's going on with Cochlear shares?
• Why is the ASX 200 stuck in the red today?
• 3 cheap ASX shares that could be hiding in plain sight
• Why A2 Milk, Calix, CSL, and Ioneer shares are charging higher today

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, ResMed, and Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Ansell, CSL, Cochlear, Pro Medicus, Sonic Healthcare, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Investors have long relied upon ASX 200 bank shares for reliable chunky dividends each year.

But can we continue to do so?

Investment firm, Market Partners, explains why it prefers another type of ASX financial share over banks for dividends these days.

Expert recommends better stocks for dividends

Instead of ASX 200 bank shares, Market Partners analysts James Gerrish and Shawn Hickman prefer insurance stocks.

The main case against the banks is not their relatively high share prices.

It's that investment loans have been powering their growth, and "that is likely to be pulled in" following the Federal Budget.

The Federal Government proposed major changes to capital gains tax (CGT) in the budget last month.

Under the changes, the 50% CGT discount for assets held longer than 12 months will be replaced by a cost base inflation indexation method from 1 July next year, and a minimum 30% CGT rate will apply.

In a webinar, Hickman, who is head of research at Market Partners' digital advice platform, Market Matters, said:

It's hard to imagine people are going to go out there aggressively in the near future and get fresh investment loans.

This may impact the earnings of the ASX 200 bank shares, which would threaten future dividends.

They're very secure businesses, but the growth factor for them to push a lot higher from here is very hard to imagine.

And that's why Market Matters is underweight.

We still own ANZ Group Holdings Ltd (ASX: ANZ). We still own Westpac Banking Corp (ASX: WBC). They're strong. They're going to make money. They're going to pay good dividends, but we don't see any reason to be overweight the banks.

While Gerrish emphasises that they are "certainly not negative on the banks" at today's share prices, investing is still "a relative game".

Gerrish explained:

… insurers benefit from higher interest rates. So they earn a higher income from their invested funds.

You pay your premiums, they invest the premiums, they earn a return on the premiums, then they pay out claims when they come up.

He points out that the insurance sector has experienced volatility for the past three or four years, but things have changed.

… now the tailwinds on the insurance side are improving, we think, and you think about insurers yielding circa 5%, banks mid-4%s.

Insurers have less economic sensitivity, banks have a greater degree of economic sensitivity relative to the insurers.

I think there's a case to be made that there's more upside in the insurers than banks.

That doesn't mean the banks don't go up from here, but there's probably more upside in terms of the insurance stocks relative to the banks.

Preferred ASX insurance share for dividends

Gerrish said Suncorp Group Ltd (ASX: SUN) is Market Matters' preferred ASX insurance share for dividends moving into FY27.

Since selling its banking division to ANZ, Gerrish reckons Suncorp has become a "simpler and safer institution".

He says a significant new reinsurance program, that takes about 2% off Suncorp's earnings, will protect future dividends for investors.

In this sort environment, where yield is really, really important, I think Suncorp stacks up here.

It trades about two P/E points cheaper than Insurance Australia Group Ltd (ASX: IAG).

I think it probably should trade more aligned with IAG.

Reinsurance protects Suncorp's earnings by transferring part of the financial risk of high payouts after major events.

Gerrish noted that climate change has raised risks and encouraged insurers to invest in reinsurance.

The experts point out that higher inflation can allow insurers to raise premiums, however it also makes repairs more expensive.

Gerrish added:

Insurance is a good business when they get their pricing discipline right and claims are benign.

That's the sort of environment that they're in now.

So insurance companies can now print a lot more money.

And the other thing around higher rates… is their investment portfolio has a long duration.

So, as they roll over fixed income — the majority is in fixed income — then they're getting higher rates of return on the investment portfolio as well.

Top ASX insurance share pick for growth

The experts said their top pick among ASX insurance shares for growth into FY27 is QBE Insurance Group Ltd (ASX: QBE).

Gerrish said:

They've been working hard over the last five, 10 years around simplification of their business.

So they went out there, they made a huge number of acquisitions… and it's starting to pay benefits.

The experts said QBE was an emerging turnaround story, with the share price trading close to 15-year highs.

Gerrish added:

Turnarounds can take a lot longer than anyone envisages.

But once a turnaround is starting to gain traction like it is in QBE, then the stock can run a lot further and a lot longer than anyone thinks.

So, on 12x [P/E], growing earnings at high single digits, yielding 4.7% part-franked [dividends] with earnings tailwinds, we think QBE stacks up.

ASX 200 bank share dividends

The trailing dividend yields of the ASX 200 bank shares are as follows:

• Commonwealth Bank of Australia (ASX: CBA) shares have a trailing dividend yield of 3% plus 100% franking
• National Australia Bank Ltd (ASX: NAB) shares have a trailing dividend yield of 4.5% plus 100% franking
• ANZ shares have a trailing dividend yield of 4.8% plus 70% to 75% franking
• Westpac shares have a trailing dividend yield of 4.3% plus 100% franking

The post Invested in ASX 200 bank shares for dividends? This fundie prefers other stocks appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Down 17%: What should I do with my Westpac shares now?
• Here's the dividend forecast out to 2027 for NAB shares
• 3 big reasons to buy CBA shares
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Wilson Asset Management says proposed changes to capital gains tax (CGT) will encourage investors into higher-yielding assets.

In the share market, that means ASX dividend shares, especially those that offer high franking, over ASX growth shares.

Under the changes announced in the Federal Budget, the 50% CGT discount for assets held longer than 12 months will be replaced by a cost base inflation indexation method from 1 July next year, and a minimum 30% CGT rate will apply.

While existing investments will be grandfathered, so the 50% CGT discount will continue to apply to gains before 1 July 2027, the rules change after that date.

That means existing investors will pay CGT based on two sets of calculations: pre-1 July 2027 gains using the 50% discount, and post-1 July 2027 gains using the inflation-indexed method.

Wilson Asset Management's view

Wilson advocated for keeping the CGT discount for ASX shares and all other assets except investment property.

In a submission to a Senate enquiry, Wilson explained that "capital flows toward the highest after-tax risk-adjusted return".

'After-tax' is the key term there.

Wilson said retail investors were likely to gravitate toward higher-yielding assets offering passive income if they have to pay more CGT.

The fundie said:

By increasing the tax burden on long-term capital gains while leaving income-producing assets comparatively more attractive, the Bills will, over time, redirect Australian savings away from growth companies, founders, venture capital and productive enterprise, and toward yield-producing assets that generate income.

Wilson manages about $6 billion for 130,000 Australian investors who own shares in its ASX listed investment companies (LICs).

Those LICs include WAM Capital Ltd (ASX: WAM), WAM Leaders Ltd (ASX: WLE), and WAM Research Limited (ASX: WAX).

Wilson said the changes would discourage investment, entrepreneurship, and economic growth, and "alter investor behaviour".

Capital will increasingly favour mature yield-producing assets rather than growth-oriented investments whose returns are realised predominantly through future capital appreciation.

Currently many of Australia's most successful businesses generate limited income in their formative years.

Investors accept risk in exchange for the prospect of long-term capital growth. The proposed tax changes reduce that outcome.

The consequence of this will be a gradual reallocation of capital … toward assets producing immediate taxable income.

Chairman and Chief Investment Officer of Wilson Asset Management, Geoff Wilson AO, also appeared before the committee.

In his speech, Wilson said:

Australia's prosperity has always depended on a simple idea: that if people work hard, save carefully and take considered risks with their capital, they can build a better future for themselves and their families.

We believe this legislation weakens that social contract.

ASX dividend shares will become more appealing: experts

Wilson Asset Management is among many professional managers who say the proposed CGT tax changes will encourage investors to pursue ASX dividend shares over ASX growth shares.

Wealth and investment advisory firm Medallion says:

At a high level, the changes tilt the playing field toward yield.

If a larger portion of capital gains is taxed away, the after-tax return profile of growth assets; equities, start-ups, and expansionary investments becomes less compelling.

In contrast, income streams such as dividends retain their relative appeal, particularly where they are franked.

Market Partners analysts James Gerrish and Shawn Hickman said income investments were already more appealing in today's economic environment.

In a webinar presentation, they said:

Sticky inflation, higher rates and geopolitical uncertainty all increase the value of tangible cash flow today.

So, when the proposed CGT changes are added on top, they concluded:

Growth still has a role, but strategies that rely heavily on after-tax capital gains look relatively less attractive.

The post Wilson Asset Management says CGT tax changes will 'redirect' investment toward yield appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• What on earth's going on with Cochlear shares?
• Liontown shares crash 18% in a month: What happened?
• Why is the ASX 200 stuck in the red today?
• 3 ASX shares with 39% to 141% growth ahead of them: Experts

Motley Fool contributor Bronwyn Allen has positions in Wam Capital. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Brent crude oil price hit a four-year high of US$114 per barrel during the war between the US and Iran.

West Texas Intermediate (WTI) crude also reached a four-year high of US$113 per barrel during the conflict.

Oil prices skyrocketed due to the effective shutdown of the Strait of Hormuz, which carries 20% of the world's oil and gas supply.

Today, all those oil price gains are gone.

Oil prices are back to pre-war levels, and ASX 200 energy shares are down sharply this week as a result.

What's the oil price today?

The Brent crude oil price is US$79.50 per barrel, and WTI is US$76.40 per barrel at the time of writing.

Brent Crude is down 9% for the week and down 24% over the month. WTI has fallen 10% this week and 22% over the month.

Oil prices began a rapid retreat in recent weeks after US President Donald Trump talked up an impending deal with Iran.

News of a US-Iran interim peace agreement earlier this week saw a final cascade in oil prices back to February levels.

The deal incorporates a 60-day ceasefire, the end of the US blockade of Iranian ports, and the reopening of the Strait of Hormuz.

Trading Economics analysts said the supply disruption caused by the 16-week war was the biggest on record.

Today, tankers are slowly moving out of the Strait of Hormuz.

The analysts said:

Tankers carrying previously stranded crude began exiting the waterway on Thursday, and Kuwait said it would begin increasing production.

As a result, oil prices have erased nearly all the gains recorded since the Middle East conflict began in late February.

While oil prices have slumped, many economists say we have yet to see the full inflationary impact of the supply shock.

In Australia, higher oil prices have contributed to three interest rate rises already this year.

What's happening with ASX 200 energy shares on Friday?

ASX 200 energy shares are in the red on Friday, with the S&P/ASX 200 Energy Index (ASX: XEJ) down 0.9%.

By comparison, the benchmark S&P/ASX 200 Index (ASX: XJO) is down 1%.

The Woodside Energy Group Ltd (ASX: WDS) share price is up 0.1% to $28.66 today, but down 7.2% over the week.

The Santos Ltd (ASX: STO) share price is 1.5% lower at $7.23, and has fallen 8.9% over five days.

The Ampol Ltd (ASX: ALD) share price is 1.4% lower at $32.88, and is 8.1% lower over the week.

The Viva Energy Group Ltd (ASX: VEA) share price is down 0.5% to $2.14, and down 1.8% over five days.

Karoon Energy Ltd (ASX: KAR) shares are 2.3% lower at $1.41, and down 25.7% this week after production downgrades.

The Beach Energy Ltd (ASX: BPT) share price is 2.5% lower at 97 cents, and down 9.8% over five days.

The post Oil prices slump to pre-war levels as supply-risk premium evaporates appeared first on The Motley Fool Australia.

More reading

• Woodside shares sink again as oil price pressure outweighs new gas deal
• With oil prices falling, should I still buy Santos shares now?
• This ASX energy stock is sliding despite a major refinery restart
• Viva Energy Group: Geelong Refinery nears full capacity after fire
• The US-Iran peace deal just wavered. Here is what this means for these ASX shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 1.1% to 8.816.7 points on Friday.

This week, brokers see new potential in several ASX shares.

Let's take a look at them.

Karoon Energy Ltd (ASX: KAR)

The Karoon Energy share price is $1.41, down 2.6% today.

Over the past month, this ASX 200 energy share has lost almost a third of its value.

Morgans upgraded Karoon Energy shares from a trim to hold rating on Tuesday.

The broker said:

A good company in a difficult position, dealing with multiple operational issues, albeit enjoying a nice bump in earnings resulting from the Middle East conflict.

Operator LLOG advised of ongoing operational issues leading to a 41% downgrade to Who Dat production in 2026, an 11% downgrade at group level. Down 20% in two sessions, KAR is trading close to our revised target price.

As a result, we lift our Trim rating to HOLD with a A$1.67 target price.

Morgans has a 12-month price target of $1.90, which implies very healthy upside of 35% ahead.

Treasury Wine Estates Ltd (ASX: TWE)

The Treasury Wine Estates share price is $4.78, down 0.6% today.

Over the past month, this ASX wine share has risen 10%.

Citi upgraded Treasury Wine Estates shares to a buy rating on Tuesday.

The broker lifted its 12-month price target from $4.25 to $5.50.

This implies a potential 15% upside ahead.

Liontown Ltd (ASX: LTR)

The Liontown share price is $1.96, down 4.1% today.

In 2026, this ASX 200 lithium share has gained 21% in value.

Lithium commodity prices are rapidly recovering from a devastating two-year decline.

The carbonate price is now 43% higher YTD, following a 58% rise in 2025.

Macquarie upgraded Liontown shares to a buy rating on Monday.

The broker lifted its 12-month price target from $2.20 to $2.30.

This implies a potential 17% upside ahead.

Evolution Mining Ltd (ASX: EVN)

The Evolution share price is $12.55, down 5% today.

In 2026, this ASX 200 gold share has dipped 1%.

Macquarie upgraded Evolution shares to a buy rating on Tuesday.

The broker shaved its 12-month price target from $14 to $13.

This suggests just 3% potential upside ahead.

Sims Ltd (ASX: SGM)

The Sims share price is $29.45, down 1.8% today.

Over the past month, this ASX industrial share has ripped 31%.

Jefferies upgraded Sims shares to a hold rating on Wednesday.

The broker lifted its 12-month price target from $19 to $31.

This indicates a potential 6% upside over the next year. 

Accent Group Ltd (ASX: AX1)

The Accent share price is 73 cents, down 0.7% today.

Over the past month, this ASX consumer discretionary share has soared 31%.

On Monday, Frasers Group plc (LSE: FRAS) made an unconditional on-market cash takeover offer of 65 cents per share.

Following the bid, Morgan Stanley upgraded Accent shares to a hold rating.

The broker has a 12-month target of 75 cents.

This suggests the ASX retail share is almost fully valued.

The post 6 ASX shares upgraded by analysts this week appeared first on The Motley Fool Australia.

More reading

• Liontown shares crash 18% in a month: What happened?
• 3 cheap ASX shares that could be hiding in plain sight
• Here are the top 10 ASX 200 shares today
• This ASX retail stock just rejected a takeover bid. Is a bigger offer coming?
• Here are the 10 most shorted ASX shares

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Jefferies Financial Group, Macquarie Group, and Treasury Wine Estates. The Motley Fool Australia has positions in and has recommended Treasury Wine Estates. The Motley Fool Australia has recommended Accent Group and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) stocks closed 0.6% lower at 8,911.1 points on Thursday.

In the calendar year to date (YTD), ASX 200 shares have lifted just 2.1%.

A major commodities sell-off in late January and the global oil shock created by the war in Iran have weighed on equities this year.

Experts say some ASX stocks have hefty falls ahead of them.

Let's take a look at five.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price closed at $162.23, down 0.9% on Thursday.

The ASX 200 bank stock is up 1% YTD.

Macquarie reiterated its sell rating on CBA shares this month.

The broker cut its 12-month price target from $114 to $111.

This implies a potential 32% downside ahead.

Sandfire Resources Ltd (ASX: SFR)

The Sandfire Resources share price closed at $21.20, down 1.4% today.

This ASX 200 copper stock is once again trading close to its record high of $21.75 set in January.

Citi predicts a significant fall from here, but has a hold rating on the ASX mining stock.

The broker has a price target of $12.20, suggesting a 40%-plus slide ahead.

The lithium stock has risen 18% YTD.

IGO Ltd (ASX: IGO)

The IGO share price closed at $8.64, down 3.4% today.

This ASX 200 lithium stock is up 5% YTD.

Morgan Stanley has a sell rating on IGO shares with a $6.85 target.

This indicates a potential 21% downside ahead.

Centuria Capital Group (ASX: CNI)

Centuria Capital stock closed at $2.18, down 0.5% today.

This ASX real estate investment trust (REIT) is up 7% YTD.

UBS has a hold rating on the ASX real estate stock with a $1.69 target.

This implies 23% potential downside ahead.

Wesfarmers Ltd (ASX: WES) 

The Wesfarmers share price closed at $85.78, up 0.3% today.

This ASX 200 consumer discretionary stock is up 5% YTD.

Wesfarmers recently held its 2026 Strategy Briefing Day.

Management told investors about Wesfarmers' growth and productivity plans, and emphasised the strong balance sheet.

Managing Director Rob Scott said Wesfarmers' main goal was to deliver satisfactory returns for shareholders.

Scott said Wesfarmers stock had delivered an average annual return of 15.8% over 10 years.

This compares to a 9.2% average annual return from the All Ordinaries Accumulation Index.

Citi kept its sell recommendation on Wesfarmers stock with a $69 target after the event.

This implies a potential 20% downside ahead.

The post Warning! 5 ASX stocks to fall 20% or more: Experts appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Why is the ASX 200 stuck in the red today?
• Why Centuria Capital, Iluka, Metcash, and Reliance Worldwide shares are falling today
• Viva Energy Group: Geelong Refinery nears full capacity after fire
• Centuria Capital Group wraps up $300m equity raise and shares resume trading

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Wesfarmers. The Motley Fool Australia has recommended Macquarie Group and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.4% to 8,934.6 points on Thursday. 

Brokers have downgraded several stocks this week.

Let's take a look at their new ratings and 12-month share price targets.

Transurban Group (ASX: TCL)

The Transurban share price is $15.06, up 1.1% today.

Over the past month, this ASX 200 industrials share has popped 4.1% higher.

Morgans downgraded Transurban shares from a hold to sell rating yesterday.

The broker said:

TCL's update indicated traffic is running below expectations. TCL also announced its exit from the Montreal market via divestment, crystallising an equity value loss.

TCL's recent share price strength (+9% since its February result and not far off all-time highs) is not reflective of the weaker traffic growth and higher interest rate environment that typically challenges TCL's valuation.

We recommend clients use the share price strength to take profits in overweight positions.

Morgans has a 12-month price target of $12.50, implying a potential 17% downside ahead.

Rio Tinto Ltd (ASX: RIO)

The Rio Tinto share price is $183.32, down 1.9% today.

Over the past six months, this ASX 200 mining share has ripped 28%.

Macquarie downgraded Rio Tinto shares to a hold rating on Tuesday.

The broker lifted its 12-month price target from $186 to $188.

This suggests only a potential 2% upside ahead.

Domino's Pizza Enterprises Ltd (ASX: DMP)

The Domino's Pizza share price is $16.25, down 0.4% today and down 26% YTD. 

This ASX 200 consumer discretionary share has tumbled 28% over six months.

Morgans downgraded its rating on Domino's Pizza shares to a hold this week.

The broker said: 

The trading environment for DMP has become more challenging than previously assumed, and we have updated our forecasts to reflect a weaker SSS (same-store-sales) outlook across all three regions, compounding cost pressures on ANZ franchisee economics, and a more adverse FX environment in Japan.

The earnings recovery, albeit modest, remains on track but it is entirely cost-driven; there is no volume improvement embedded in our numbers until outer years.

We move to a HOLD rating until there is evidence of further cost management and SSS recovery.

The broker reduced its price target on Domino's Pizza shares from $25 to $17.60.

This indicates potential capital gains of 8% over the next year. 

Wesfarmers Ltd (ASX: WES)

The Wesfarmers share price is $86.43, up 1.1% today.

Over the past month, this ASX 200 retail share has soared 21%.

Macquarie downgraded Wesfarmers shares to a hold rating with an $85 target.

This suggests the stock is fully valued today.

The post 4 ASX 200 shares downgraded by brokers this week appeared first on The Motley Fool Australia.

More reading

• Forget BHP and Rio Tinto, this ASX copper share could rise 100%+
• Where to invest $500 on the ASX right now
• Transurban Group overhauls NSW toll enforcement, ditches paper notices
• 3 reasons why the Wesfarmers share price is a buy
• The ASX investing strategy that could quietly make you rich

Motley Fool contributor Bronwyn Allen has positions in Domino’s Pizza Enterprises. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Domino’s Pizza Enterprises, Macquarie Group, Transurban Group, and Wesfarmers. The Motley Fool Australia has positions in and has recommended Transurban Group. The Motley Fool Australia has recommended Domino’s Pizza Enterprises, Macquarie Group, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.4% to 8,929.7 points on Thursday. 

The materials sector, including ASX lithium shares, is underperforming the broader market today, down 0.7%.

Lithium is among the best-performing commodities of 2026.

Lithium is well into a substantial recovery powered by the green energy transition and demand for batteries and electric vehicles (EVs).

The oversupply that smashed lithium prices for two years between mid-2023 and mid-2025 is over.

Producers that put their mines into care and maintenance, such as Core Lithium Ltd (ASX: CXO), are restarting as demand begins to outstrip supply worldwide.

Exemplying the trend, the lithium carbonate price is now up 43% in the calendar year to date (YTD), following a 58% increase in 2025.

With all this in mind, let's check out 3 ASX lithium shares with new ratings from Bell Potter this week.

PLS Group Ltd (ASX: PLS)

The PLS Group share price is $6.27, down 1.5% today and up 45% YTD. 

Formerly Pilbara Minerals, PLS Group's flagship mine is the Pilgangoora Lithium-Tantalum Project in the Pilbara area of Western Australia.

Bell Potter reiterated a hold rating on the market's largest ASX lithium share this week.

The broker said: 

At current lithium market prices, PLS will generate substantial earnings and cash flow with the restart of the 200ktpa Ngungaju processing plant.

P2000 and Colina development studies are being progressed, providing substantial organic growth optionality in markets with strong underlying EV and BESS-led long term demand fundamentals.

The broker lifted its 12-month share price target on PLS Group shares from $5.50 to $6.15.

Liontown Ltd (ASX: LTR)

The Liontown share price is $2.07, down 3.1% today and up 27% YTD. 

Liontown owns the Kathleen Valley project in Western Australia.

Bell Potter analyst Stuart Howe maintained a buy rating on this ASX lithium share this week.

Howe increased his expectations for growth in the lithium spodumene concentrate (6% Li2O) price by 11% for the rest of 2026, 7% in 2027, and 17% in 2028.

He also lifted Bell Potter's long-term spodumene concentrate price to US$1,500 per tonne, up from US$1,400 per tonne.

Howe said: 

LTR is now in a net cash position. Over FY26-27, LTR will continue to ramp up and de-risk Kathleen Valley.

With current lithium price strength, LTR can rapidly generate cash to support incremental production expansions and shareholder returns.

Kathleen Valley is highly strategic in terms of scale, long project life and location in a tier-one mining jurisdiction.

LTR has offtake contracts with top-tier EV and battery OEMs.

Howe increased the 12-month target from $2.65 to $2.90 for Liontown shares.

Wildcat Resources Ltd (ASX: WC8)

The Wildcat Resources share price is 57 cents, up 3.1% today and up 51% YTD. 

WC8 is progressing its hard rock lithium development, Tabba Tabba, in the Pilbara.

Analyst James Williamson commenced coverage on this ASX lithium share with a speculative buy rating this week.

Williamson said: 

Tabba Tabba is the only large scale near-term Australian lithium development positioned to commence production during the current lithium price cycle.

The project is strategically located 80km from Port Hedland and WC8 enters financing discussions with 100% of offtake uncommitted.

The company trades on undemanding EV/Resource multiples compared with Western Australian spodumene producers.

We expect its share price will re-rate as Tabba Tabba reaches key feasibility and permitting milestones and transitions into development.

However, Williamson warns:

WC8 is an asset development company with forecast cash flows only; our Speculative risk rating recognises this higher level of investment risk and share price volatility.

Willamson gives this ASX lithium share a $1 valuation.

The post Buy, hold, sell: Liontown, Wildcat Resources, PLS Group shares appeared first on The Motley Fool Australia.

More reading

• Liontown shares crash 18% in a month: What happened?
• PLS shares drop 5%: What's driving the move?
• Why Humm, Metcash, PLS, and WiseTech shares are sinking today
• Top brokers name 3 ASX shares to buy next week
• Why Aeris, Newmont, PLS, and REA Group shares are tumbling today

Motley Fool contributor Bronwyn Allen has positions in Core Lithium. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX mining shares are lower on Thursday, with the S&P/ASX 300 Metal & Mining Index (ASX: XMM) down 0.7%.

The ASX 300 mining Index is 22% higher in the calendar year to date (YTD). This follows last year's spectacular 38% growth.

A new commodities super cycle is underway, with lithium and copper among the best performers in 2026.

By comparison, the S&P/ASX 300 Index (ASX: XJO) is up 2% this year and rose 7% last calendar year.

Major diversified miners, including Rio Tinto Ltd (ASX: RIO), have reset their historical highs this year amid rising commodity prices.

The Rio Tinto share price hit a new record of $195.84 on 3 June.

Copper miner Sandfire Resources Ltd (ASX: SFR) hit a record $21.75 on 30 January.

The ASX copper mining share then retreated for a period before returning to near-record highs this month.

Yesterday, Sandfire Resources shares traded at an intraday high of $21.64.

Despite the new mining boom now underway, experts don't have buy ratings on ASX mining shares across the board.

On The Bull this week, Warwick Grigor from Far East Capital names two mining stocks to sell.

But in both cases, the sell recommendation is for the best reason possible: to take enormous profits.

Southern Cross Gold Consolidated (ASX: SX2)

The Southern Cross Gold share price is $4.51, down 2.6% today but up a whopping 82% YTD. 

Grigor has a sell rating on this ASX gold mining share.

He explains:

The gold company operates three exploration projects. Two projects are in Victoria and one is in Queensland.

The company has reported high grade assays, most recently from the Sunday Creek Gold-Antimony project in Victoria where it drilled seven holes.

Any JORC mineral resource estimate in the future needs to meet investor expectations, or the share price may be punished.

The shares rose from $5.37 on August 1, 2025 to $12.04 on March 2, 2026. The shares were trading at $8.75 on June 11.

Investors may want to consider taking a profit.

Almonty Industries CDI (ASX: AII)

The Almonty Industries share price is $26.42, up 1.1% today and doubling in value YTD. 

Grigor recommends selling this ASX tungsten mining share.

Almonty supplies conflict free tungsten, a strategic metal critical to the defence and advanced technology sectors.

The company is continuing to ramp up its tungsten mining operations in South Korea.

The company has ridden the tungsten boom and benefited from soaring tungsten prices.

However, the share price rise is losing momentum. It now has to deliver on some aggressive earnings estimates to justify its rating.

The shares have fallen from $32.51 on April 21 to trade at $22.18 on June 11. It may be time to cash in some gains.

The post 2 ASX mining stocks to sell after strong runs: expert appeared first on The Motley Fool Australia.

More reading

• Up 74% since August, ASX 300 gold stock hits new high-grade zones in Victoria
• 3 ASX mining shares to buy: experts
• Buy, hold, sell: Southern Cross Gold, Healius, Centuria Office REIT shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares recovered early losses to close just inside the green after interest rates were kept on hold yesterday.

ASX 200 shares had been sharply lower in early trading but moved up immediately after the rates announcement at 2.30pm.

The ASX 200 closed 0.042% higher at 8,917.7 points.

Meanwhile, brokers indicated continuing confidence in several ASX 200 shares by renewing their buy recommendations.

Let's take a look.

Resmed CDI (ASX: RMD)

The Resmed share price closed 1.3% lower at $27.39 on Tuesday.

Over the past six months, this ASX 200 healthcare share has fallen 28%.

Citi renewed its buy rating on Resmed shares this week.

The broker cut its 12-month price target substantially from $48 to $38.

This still suggests a potential near-40% upside ahead.

NextDC Ltd (ASX: NXT)

The NextDC share price closed 0.4% higher at $14.87 on Tuesday.

This ASX 200 tech share has risen 21% in the calendar year to date (YTD) amid a broader sector rebound.

Citi reiterated its buy rating on NextDC shares on Monday with a price target of $19.10.

This implies potential capital gains of almost 30% ahead.

Mineral Resources Ltd (ASX: MIN)

The Mineral Resources share price finished at $70.79, down 0.9%, yesterday.

Over the past six months, this ASX 200 mining share has soared 40%.

Bell Potter reaffirmed its buy rating on Mineral Resources shares on Monday.

The broker lifted its 12-month target from $80.50 to $83.

This suggests a potential 17% upside ahead.

Newmont Corporation CDI (ASX: NEM)

The Newmont share price finished at $150.16 on Tuesday, up 2%.

This ASX 200 gold share has been volatile in 2026, and is down 0.6% YTD.

Macquarie renewed its buy rating on Newmont shares on Tuesday.

The broker lowered its 12-month target from $192 to $176.

This implies potential capital growth of 17% over the next year.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price finished yesterday's trading session at $9.96, up 0.2%.

The ASX 200 airline share has ripped 18% over the past month.

UBS renewed its buy rating on Qantas with a $11.15 share price target.

This suggests a potential 12% upside ahead.

Goodman Group (ASX: GMG)

The Goodman share price closed at $32.26 on Tuesday, up 0.6%.

This ASX 200 real estate share has popped 7% higher over this past month of trading.

Bell Potter reiterated its buy rating on Goodman shares on Monday with a price target of $35.50.

This implies a potential 10% upside ahead.

Goodman announced a dividend of 15 cents per share for 2H FY26 on Tuesday.

The ex-dividend date is 29 June. Investors will receive their dividend on 26 August.

The post 6 ASX 200 shares with fresh buy ratings this week appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Why is the ASX 200 stuck in the red today?
• Viva Energy Group: Geelong Refinery nears full capacity after fire
• Centuria Capital Group wraps up $300m equity raise and shares resume trading
• Reliance Worldwide closes Australian brass sites

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.4% to 8,881.5 points on Tuesday.

Let's check out three shares with new ratings from the experts. 

WiseTech Global Ltd (ASX: WTC)

The WiseTech share price is $37.11, down 3.4% today and down 46% in the calendar year to date (YTD). 

Bell Potter reiterated its buy rating on this ASX 200 tech share but cut its 12-month price target last week.

The broker said: 

WiseTech CEO Zubin Appoo said at the 1HFY26 result in February he was "confident and hopeful" that the company would migrate some of the remaining 5% of customers – representing c.30% of CargoWise revenue – across to CargoWise Value Packs (CVP) this financial year.

As of yet, however, there has been no announcement or indication that one or more of these customers have moved across so we suspect it is proving more difficult or at least more time consuming to achieve this outcome.

As a result we are modestly reducing our CargoWise revenue forecasts in the short to medium term given we expect this transition to provide a boost to revenue with the shift to transaction-based pricing.

We also see some risk that WiseTech may have to provide greater incentives for these customers to shift – such as transitional price
protection (TPP) or additional training – which would also have a negative impact.

Bell Potter reduced its 12-month price target from $78.75 to $71.75.

Ampol Ltd (ASX: ALD)

The Ampol share price is $34.17, up 1.1% today and up 6% YTD. 

Andrew Wielandt from DP Wealth Advisory has hold rating on this ASX 200 energy share. 

Wielandt commented on The Bull:

Ampol is Australia's biggest petrol and convenience network. It also owns the Lytton oil refinery in Queensland.

The Middle East crisis is positive for the company's refining margins and earnings growth is expected to continue moving forward. The convenience retail segment provides the benefit of diversification.

A significantly increasing share price in the past 12 months reflects market optimism, so ALD remains a hold at these levels.

Lotus Resources Ltd (ASX: LOT)

The Lotus Resources share price is 59 cents, up 1.2% today and down 72% YTD. 

Lotus Resources is a uranium producer. It is developing the Kayelekera mine in Malawi and the Letlhakane project in Botswana.

Elio D'Amato from EnviroInvest has a sell rating on this ASX uranium share. 

D'Amato explained: 

Uranium plays an important role in reducing global emissions and it's encouraging the Kayelekera mine is moving towards steady-state production.

However, the latest quarterly report highlighted several operational challenges, including lower-than-expected recoveries, re-agent shortages and the withdrawal of previously reported grade and recovery figures while reconciliation processes are reviewed.

The company remains well funded and believes these issues are manageable.

Even so, in our view, operational uncertainty during a critical production ramp-up phase increases risk and warrants a more cautious approach.

The post Buy, hold, sell: WiseTech, Lotus Resources, Ampol shares appeared first on The Motley Fool Australia.

More reading

• 3 cheap ASX shares that could be hiding in plain sight
• WiseTech shares rebound 5%, responds to media reports: Is it time for investors to buy back in?
• WiseTech shares just crashed. Can investors look past the company's governance issues?
• Why Humm, Metcash, PLS, and WiseTech shares are sinking today
• WiseTech shares crash 12% as founder scandal deepens

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Space Exploration Technologies Corp (NASDAQ: SPCX) shares sure did achieve lift-off!

SpaceX shares have rocketed 40% in just two days of trading, closing at US$192.50 overnight.

The largest initial public offering (IPO) in history raised US$75 billion at US$135 per share last Friday.

The IPO made founder Elon Musk, who also founded Tesla Inc (NASDAQ: TSLA), the world's first trillionaire.

What happened with SpaceX shares?

The stock debuted on the Nasdaq Composite Index (NASDAQ: .IXIC) at midday on Friday (Saturday night Aussie time).

SpaceX shares closed 19.2% higher at US$160.95 on their first part-day of trading.

Overnight, SpaceX shares soared again in their first full trading session, gaining 19.6% to close at US$192.50.

In after hours trading, SpaceX shares are currently 12.1% higher at US$215.80.

SpaceX shares now have a market capitalisation of US$2.52 trillion.

That makes the company the seventh most valuable business in the S&P 500 Index (SP: .INX).

Its worth has already exceeded Tesla, which has a market cap of US$1.54 trillion, and is now in ninth place.

What does SpaceX do?

SpaceX offers rocket launch and satellite internet services.

Starlink is the satellite internet business. It uses thousands of satellites in low-Earth orbit to deliver broadband internet services via subscription.

SpaceX also offers launch services with its Falcon 9 and Falcon Heavy rockets to satellite companies, governments, and space agencies.

The longer-term ambition is to develop Starship, a next-generation rocket and spacecraft system capable of carrying large cargo into space and supporting missions to the Moon and Mars.

The company also owns xAI and is investing in artificial intelligence (AI) infrastructure.

What do the experts think of SpaceX shares?

The first lot of ratings and 12-month share price targets from brokers reveals differing views.

Global brokerage and investment bank Oppenheimer initiated coverage on SpaceX shares with a buy rating.

In an article, analyst Timothy Horan said:

We believe SpaceX represents an opportunity to own a leading AI and connectivity giant, while also capturing the optionality of space economies.

We see its ownership of critical/unique data, LLM capabilities, and control over scarce computer chips and infrastructure as giving it a major cost and service advantage that should enable it to raise the capital required for the build.

We believe the company is the only one with the required capital access, people, manufacturing, data and technology to be a disruptive entrant in connectivity, AI, and space, and to ultimately be a leader in these industries.

In just two days of trading, SpaceX shares have already gone beyond Oppenheimer's initial 12-month price target of $190.

Independent sell-side research firm, Wolfe Research, also has a buy rating on SpaceX shares. Its 12-month target is $175.

Global independent investment research house, CFRA, reckons retail investors should take their already massive profits and run.

CFRA has a sell rating on SpaceX shares with a $115 target. This implies a potential 40% downside from here.

CFRA refers to "extraordinary risks" in a detailed report by senior analyst, Keith Snyder.

The company said: "SpaceX isn't just a rocket company – it's a space industrial, a global telco, and a frontier AI lab all rolled into one."

The post SpaceX shares rocket 40% in 2 days. How do the experts rate this stock? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• What on earth's going on with Cochlear shares?
• Liontown shares crash 18% in a month: What happened?
• Why is the ASX 200 stuck in the red today?
• 3 ASX shares with 39% to 141% growth ahead of them: Experts

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Australian investors have $353 billion invested across 451 ASX exchange-traded funds (ETFs) on the market today.

This week on The Bull, Andrew Wielandt of DP Wealth Advisory offers his recommendations as to which ones to buy.

Let's take a look.

Milford Australian Absolute Growth Complex ETF (ASX: MFOA)

The Milford Australian Absolute Growth Complex ETF is steady at $11.46 apiece today.

This ASX ETF invests in a diversified portfolio of predominantly ASX shares, as well as some international equities and cash. 

Wielandt explains his buy rating on this ASX ETF:

The fund aims to generate returns of 5 per cent above the Reserve Bank of Australia's cash rate.

The fund also aims to preserve capital in times of uncertainty.

Major holdings included BHP Group Ltd (ASX: BHP), National Australia Bank Ltd (ASX: NAB) and Westpac Banking Corp (ASX: WBC) shares.

This ETF proved its resilience during market volatility in March 2026.

The ETF has risen from $10.87 on June 12, 2025 to trade at $11.31 on June 11, 2026.

We like MFOA's outlook in volatile and stable times.

The RBA's cash rate is 4.35% after three increases already in 2026 due to resurgent inflation.

The RBA will announce its next interest rate call this afternoon at 2:30pm.

This ASX ETF's management fee is 0.9%.

Betashares FTSE Rafi Australia 200 ETF (ASX: QOZ)

The Betashares FTSE Rafi Australia 200 ETF is down 0.2% at $19.51 apiece on Tuesday.

Wielandt likes this ASX ETF because it considers the fundamental size or economic footprint of a business, rather than just its market capitalisation. As a result, it focuses more on value shares within the S&P/ASX 200 Index (ASX: XJO).

Betashares explains the strategy:

The index which QOZ aims to track provides exposure to a diversified portfolio of Australian equities, weighted in a way that is reflective of the economic importance rather than the market capitalisation of its constituents.

Constituent weighting is based on accounting values and is known as "Fundamental indexing".

Portfolio holdings included BHP shares, Commonwealth Bank of Australia (ASX: CBA), and Woodside Energy Group Ltd (ASX: WDS).

Wielandt also has a buy rating on this ASX ETF.

He comments:

The ETF has posted returns of 10.87 per cent per annum over the past five years and 19.12 per cent in the past year to May 29, 2026.

Consistent performance is appealing during volatile times.

The management fee is 0.4%.

The post 2 ASX ETFs to buy: expert appeared first on The Motley Fool Australia.

More reading

• Should I buy the dip on Ampol shares today?
• We're back in a value market: Here's 3 ASX ETFs to target

Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.